SELLAS Life Sciences (SLS) EPS (Weighted Average and Diluted) (2020 - 2023)
Historic EPS (Weighted Average and Diluted) for SELLAS Life Sciences (SLS) over the last 5 years, with Q4 2023 value amounting to -$0.29.
- SELLAS Life Sciences' EPS (Weighted Average and Diluted) rose 3153.98% to -$0.29 in Q4 2023 from the same period last year, while for Sep 2024 it was -$0.12, marking a year-over-year increase of 9132.03%. This contributed to the annual value of -$1.36 for FY2023, which is 3599.45% up from last year.
- As of Q4 2023, SELLAS Life Sciences' EPS (Weighted Average and Diluted) stood at -$0.29, which was up 3153.98% from -$0.33 recorded in Q3 2023.
- SELLAS Life Sciences' 5-year EPS (Weighted Average and Diluted) high stood at -$0.16 for Q1 2021, and its period low was -$1.05 during Q1 2022.
- Over the past 4 years, SELLAS Life Sciences' median EPS (Weighted Average and Diluted) value was -$0.42 (recorded in 2021), while the average stood at -$0.44.
- Per our database at Business Quant, SELLAS Life Sciences' EPS (Weighted Average and Diluted) surged by 5454.55% in 2021 and then crashed by 55625.0% in 2022.
- Over the past 4 years, SELLAS Life Sciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.47 in 2020, then rose by 9.84% to -$0.42 in 2021, then dropped by 2.38% to -$0.43 in 2022, then soared by 31.54% to -$0.29 in 2023.
- Its EPS (Weighted Average and Diluted) stands at -$0.29 for Q4 2023, versus -$0.33 for Q3 2023 and -$0.32 for Q2 2023.